These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 9875320

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.
    Trkola A, Ketas TJ, Nagashima KA, Zhao L, Cilliers T, Morris L, Moore JP, Maddon PJ, Olson WC.
    J Virol; 2001 Jan; 75(2):579-88. PubMed ID: 11134270
    [Abstract] [Full Text] [Related]

  • 6. GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia.
    Si Q, Cosenza M, Zhao ML, Goldstein H, Lee SC.
    Glia; 2002 Aug; 39(2):174-83. PubMed ID: 12112368
    [Abstract] [Full Text] [Related]

  • 7. Effect of cytokines on Siglec-1 and HIV-1 entry in monocyte-derived macrophages: the importance of HIV-1 envelope V1V2 region.
    Jobe O, Trinh HV, Kim J, Alsalmi W, Tovanabutra S, Ehrenberg PK, Peachman KK, Gao G, Thomas R, Kim JH, Michael NL, Alving CR, Rao VB, Rao M.
    J Leukoc Biol; 2016 Jun; 99(6):1089-106. PubMed ID: 26667473
    [Abstract] [Full Text] [Related]

  • 8. Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression.
    Wang J, Roderiquez G, Oravecz T, Norcross MA.
    J Virol; 1998 Sep; 72(9):7642-7. PubMed ID: 9696868
    [Abstract] [Full Text] [Related]

  • 9. Regulation of human immunodeficiency virus type 1 infection, beta-chemokine production, and CCR5 expression in CD40L-stimulated macrophages: immune control of viral entry.
    Cotter RL, Zheng J, Che M, Niemann D, Liu Y, He J, Thomas E, Gendelman HE.
    J Virol; 2001 May; 75(9):4308-20. PubMed ID: 11287580
    [Abstract] [Full Text] [Related]

  • 10. Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection.
    Gross E, Amella CA, Pompucci L, Franchin G, Sherry B, Schmidtmayerova H.
    J Leukoc Biol; 2003 Nov; 74(5):781-90. PubMed ID: 12960233
    [Abstract] [Full Text] [Related]

  • 11. Granulocyte-macrophage colony-stimulating factor inhibits HIV-1 replication in monocyte-derived macrophages.
    Kedzierska K, Maerz A, Warby T, Jaworowski A, Chan H, Mak J, Sonza S, Lopez A, Crowe S.
    AIDS; 2000 Aug 18; 14(12):1739-48. PubMed ID: 10985310
    [Abstract] [Full Text] [Related]

  • 12. Is decreased HIV-1 infectivity of placental macrophages caused by high levels of beta-chemokines?
    Meléndez J, García V, Sánchez E, Delgado R, Torres G, Meléndez-Guerrero LM.
    Cell Mol Biol (Noisy-le-grand); 2001 Aug 18; 47 Online Pub():OL51-9. PubMed ID: 11936874
    [Abstract] [Full Text] [Related]

  • 13. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs.
    Torre VS, Marozsan AJ, Albright JL, Collins KR, Hartley O, Offord RE, Quiñones-Mateu ME, Arts EJ.
    J Virol; 2000 May 18; 74(10):4868-76. PubMed ID: 10775626
    [Abstract] [Full Text] [Related]

  • 14. Dendritic cell-specific intercellular adhesion molecule-3 grabbing nonintegrin mediates HIV-1 infection of and transmission by M2a-polarized macrophages in vitro.
    Cassol E, Cassetta L, Rizzi C, Gabuzda D, Alfano M, Poli G.
    AIDS; 2013 Mar 13; 27(5):707-16. PubMed ID: 23211775
    [Abstract] [Full Text] [Related]

  • 15. PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes.
    Kawamura T, Bruse SE, Abraha A, Sugaya M, Hartley O, Offord RE, Arts EJ, Zimmerman PA, Blauvelt A.
    J Virol; 2004 Jul 13; 78(14):7602-9. PubMed ID: 15220435
    [Abstract] [Full Text] [Related]

  • 16. Suppression of HIV replication in human monocyte-derived macrophages induced by granulocyte/macrophage colony-stimulating factor.
    Matsuda S, Akagawa K, Honda M, Yokota Y, Takebe Y, Takemori T.
    AIDS Res Hum Retroviruses; 1995 Sep 13; 11(9):1031-8. PubMed ID: 8554900
    [Abstract] [Full Text] [Related]

  • 17. Human immunodeficiency virus type 1 infection inhibits granulocyte-macrophage colony-stimulating factor-induced activation of STAT5A in human monocyte-derived macrophages.
    Warby TJ, Crowe SM, Jaworowski A.
    J Virol; 2003 Dec 13; 77(23):12630-8. PubMed ID: 14610185
    [Abstract] [Full Text] [Related]

  • 18. Macrophage colony-stimulating factor enhances the susceptibility of macrophages to infection by human immunodeficiency virus and reduces the activity of compounds that inhibit virus binding.
    Bergamini A, Perno CF, Dini L, Capozzi M, Pesce CD, Ventura L, Cappannoli L, Falasca L, Milanese G, Caliò R.
    Blood; 1994 Nov 15; 84(10):3405-12. PubMed ID: 7524738
    [Abstract] [Full Text] [Related]

  • 19. Consistent and significant inhibition of human immunodeficiency virus type 1 envelope-mediated membrane fusion by beta-chemokines (RANTES) in primary human macrophages.
    Stantchev TS, Broder CC.
    J Infect Dis; 2000 Jul 15; 182(1):68-78. PubMed ID: 10882583
    [Abstract] [Full Text] [Related]

  • 20. Cystamine inhibits HIV type 1 replication in cells of monocyte/macrophage and T cell lineages.
    Ho WZ, Zhu XH, Song L, Lee HR, Cutilli JR, Douglas SD.
    AIDS Res Hum Retroviruses; 1995 Apr 15; 11(4):451-9. PubMed ID: 7632461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.